WO2017201331A3 - Oligonucleotide sequences for detection of low abundance target sequences and kits thereof - Google Patents
Oligonucleotide sequences for detection of low abundance target sequences and kits thereof Download PDFInfo
- Publication number
- WO2017201331A3 WO2017201331A3 PCT/US2017/033401 US2017033401W WO2017201331A3 WO 2017201331 A3 WO2017201331 A3 WO 2017201331A3 US 2017033401 W US2017033401 W US 2017033401W WO 2017201331 A3 WO2017201331 A3 WO 2017201331A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- detection
- sequences
- kits
- low abundance
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present disclosure relates to the detection of target nucleic acid sequences present in low-abundance relative to corresponding non-target or wild-type nucleic acid sequence in a sample. In particular, compositions comprising oligonucleotide sequences suitable for use in enrichment and amplification methods allow for a substantially greater level of detection sensitivity of mutant or target sequence within a high background of wild type sequence.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662339537P | 2016-05-20 | 2016-05-20 | |
| US62/339,537 | 2016-05-20 | ||
| US201662370924P | 2016-08-04 | 2016-08-04 | |
| US62/370,924 | 2016-08-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2017201331A2 WO2017201331A2 (en) | 2017-11-23 |
| WO2017201331A3 true WO2017201331A3 (en) | 2017-12-21 |
Family
ID=60326213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2017/033401 Ceased WO2017201331A2 (en) | 2016-05-20 | 2017-05-18 | Oligonucleotide sequences for detection of low abundance target sequences and kits thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2017201331A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3814500A4 (en) * | 2018-06-27 | 2022-03-16 | The Trustees of Indiana University | PROCEDURE FOR ANALYZING DNA IN URINE |
| CN116064753B (en) * | 2018-08-28 | 2026-04-14 | 深圳联合医学科技有限公司 | High-efficiency sequencing library construction method, primer set and kit |
| US20250340934A1 (en) * | 2024-05-06 | 2025-11-06 | Gt Molecular, Inc. | Selective blocking to detect and amplify low abundant template |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130005585A1 (en) * | 2011-05-20 | 2013-01-03 | Fluidigm Corporation | Nucleic acid encoding reactions |
-
2017
- 2017-05-18 WO PCT/US2017/033401 patent/WO2017201331A2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130005585A1 (en) * | 2011-05-20 | 2013-01-03 | Fluidigm Corporation | Nucleic acid encoding reactions |
Non-Patent Citations (2)
| Title |
|---|
| ASCIERTO, PA ET AL.: "The Role of BRAF V600 Mutation in Melanoma", JOURNAL OF TRANSLATIONAL MEDICINE, vol. 10, no. 85, 9 July 2012 (2012-07-09), pages 1 - 9, XP021126777 * |
| YO, J ET AL.: "Detection of BRAF Mutations from Solid Tumors using TumorplexTM Technology", METHODSX, vol. 2, 12 June 2015 (2015-06-12), pages 316 - 322, XP055450361 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017201331A2 (en) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015159292A3 (en) | A method and kit for determining the tissue or cell origin of dna | |
| EP3543362A3 (en) | Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species | |
| WO2017044993A3 (en) | Nucleic acid analysis by joining barcoded polynucleotide probes | |
| WO2016205745A3 (en) | Cell sorting | |
| WO2016033251A3 (en) | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation | |
| WO2015200717A3 (en) | Pcr-activated sorting (pas) | |
| WO2016100955A3 (en) | Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins | |
| EP4488383A3 (en) | Methods for assessing risk using total and specific cell-free dna | |
| MX2016016898A (en) | Methods and compositions for sample analysis. | |
| WO2015119941A3 (en) | Genome fractioning | |
| WO2016057951A3 (en) | Crispr oligonucleotides and gene editing | |
| WO2012095639A3 (en) | Methods, compositions, and kits for determing the presence/absence of a varian nucleic acid sequence | |
| WO2016130868A3 (en) | Materials and methods to analyze rna isoforms in transcriptomes | |
| WO2014138119A3 (en) | Method and kit for characterizing microorganisms | |
| EP4671381A3 (en) | Methods for synthesis and detection of nucleic acids | |
| WO2012064978A3 (en) | Compositions, methods, and kits for detecting and identifying mycobacteria | |
| WO2016059474A3 (en) | Sequence conversion and signal amplifier dna having poly dna spacer sequences and detection methods using same | |
| GB2542576A (en) | Method and kit of detecting the absence of micro-oranisms | |
| WO2017201331A3 (en) | Oligonucleotide sequences for detection of low abundance target sequences and kits thereof | |
| WO2012034130A3 (en) | Methods and compositions for nucleic acid detection | |
| CA3077390A1 (en) | Methods and compositions for nucleic acid detection | |
| WO2015176006A3 (en) | Genetic detection platform | |
| WO2015127201A8 (en) | Hiv-2 nucleic acids and methods of detection | |
| WO2019045532A3 (en) | Evaluation of performance of components using a pair of dimer-forming primers | |
| WO2020132408A3 (en) | Compositions and methods for detecting plasmodium species nucleic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17800197 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 17800197 Country of ref document: EP Kind code of ref document: A2 |